Research Category

Global Vaccine Market Forecast to 2012 2010-4-27 12:5

Publisher:

Published:

Apr. 2010

Format:

PDF

Price:

US$2000.00 Single User PDF

Pages:

140

Key Words:

Global Vaccine Market

Are you interested in custom research?(click here)

Summary

Vaccine has emerged as one of the most profitable business segments in the healthcare industry. The segment registered revenues of around US$ 27 Billion in 2009. The growth has been driven by the emergence of some new chronic diseases and increasing demand for seasonal flu vaccines. Besides, the future growth of the vaccine market is anticipated to be driven by launch of several new vaccines, increasing trend of routine immunization and increasing support from the governments of various countries.

Our new research report "Global Vaccine Market Forecast to 2012" says that the vaccine industry is anticipated to enjoy a double digit growth in future. In future, it is expected that growth in demand for adult vaccines will outpace the growth in demand for pediatric vaccines. At present, the adult vaccine segment is characterised by increasing demand in the section like influenza and Hib.

Our report has found that M&A activity in the vaccine segment is likely to occur at a rapid pace than before. We have seen the recent activities have been led by pharma majors like Pfizer, Novartis and others and these companies are looking to expand their reach in emerging markets. So, most of the mergers and acquisitions are likely to occur at regional level markets. Besides, the report also provides information on various industry trends and their impact on the growth of the industry, which will give a clear industry insight to our clients.

The report also provides extensive information and rational analysis on the global vaccine market as well as on the facts like increasing investments in research and development of new products. Thus, it provides valuable information to pharmaceutical & healthcare companies and investors looking to enter into this segment. Analysis and statistics regarding market size, growth, share, regulatory environment and trends in technology development have been thoroughly analyzed in the report to present a comprehensive overview of the market to clients.

Table of Contents

1. Analyst View
2. Research Methodology
3. Market Overview
4. Key Market Drivers
4.1 Improved Routine Immunization
4.2 New Vaccine Introduction
4.3 High Investments
4.4 Support from Government and NGOs
5. Industry Performance and Future Trends
6. Major Vaccine Segments
6.1 Basic Pediatrics
6.2 Enhanced Pediatrics
6.3 Proprietary Pediatrics
6.4 Adult Vaccines
7. Pediatric Vaccines
7.1 Pneumococcal
7.2 Polio
7.3 Varicella
7.4 Rotavirus
7.5 DTP
7.6 Measles, Mumps & Rubella (MMR)
7.7 Tuberculosis
8. Adult/Travel & Therapeutic Vaccines
8.1 Hepatitis B
8.2 Malaria
8.3 Japanese Encephalitis
8.4 Typhoid
8.5 West Nile
8.6 HIV
8.7 Cancer
8.8 Influenza
9. Key Geographical Markets
9.1 US
9.1.1 Market Overview
9.1.2 Key Players
9.1.3 Product Portfolio
9.2 Europe
9.2.1 Market Overview
9.2.2 Key Players
9.2.3 Product Portfolio
9.3 China
9.3.1 Market Overview
9.3.2 Key Players
9.3.3 Product Portfolio
9.4 India
9.4.1 Market Overview
9.4.2 Key Players
9.4.3 Product Portfolio
9.5 Japan
9.5.1 Market Overview
9.5.2 Key Players
9.5.3 Product Portfolio
9.6 Brazil
9.6.1 Market Overview
9.6.2 Key Players
9.6.3 Product Portfolio
10. Investment Risk in Vaccine Industry
10.1 High R&D Cost
10.2 Lack of Infrastructure for Trials and Manufacturing
10.3 Vaccine Supply
10.4 Ineffective Distribution
11. Key Mergers & Acquisitions
12. Key Vaccine Brands Forecast to 2012
13. Competitive Landscape
13.1 Vaccine Majors
   13.1.1 Sanofi-Aventis
   13.1.2 Novartis
13.2 Vaccine-focused Biotech Companies
   13.2.1 GSK
   13.2.2 Pfizer
13.3 Domestic-focused Vaccine Companies
   13.3.1 Merck & Co.

List of Figures:

Figure 4-1: Global-Vaccine Market by Source of Funding (%), 2005 to 2010
Figure 5-1: Global-Vaccine Market (Billion USS), 2009-2012
Figure 6-1: Global-Basic Pediatric Vaccine Market (Million US$), 2007-2012
Figure 6-2: Global-Enhanced Pediatric Vaccine Market (Billion US$), 2007-2012
Figure 6-3: Global-Proprietary Pediatric Vaccine Market (Billion US$), 2007-2012
Figure 6-4: Global-Share of Adult Vaccine Sales in Vaccine Market (2008 & 2009)
Figure 6-5: Global-Adult Vaccine Market (Billion US$), 2007-2012
Figure 7-1: Global-Pneumococcal Vaccine Market (Billion US$), 2007, 2008 & 2012
Figure 7-2: Global-Number of Polio Incidences (2007-2009)
Figure 7-3: Global-Polio Vaccine Market (Million US$), 2004 & 2011
Figure 7-4: Global-Varicella Vaccine Market (Million US$), 2007 & 2008
Figure 7-5: Global-Rotavirus Vaccine Market (Million US$), 2008 & 2010
Figure 7-6: Global-Forecast for Rotavirus Vaccine Market by Region (%), 2010
Figure 7-7: Global-Number of Diphtheria Incidences by Region (2008)
Figure 7-8: Global-Number of Pertussis Incidences by Region (2008)
Figure 7-9: Global-Number of nTetanus Incidences by Region (2008)
Figure 7-10: Global-Number of tTetanus Incidences by Region (2008)
Figure 7-11: Global-Share of GSK in DTP Combos Market
Figure 7-12: Global-Number of Measles Incidences by Region (2008)
Figure 7-13: Global-Number of Mumps Incidences by Region (2008)
Figure 7-14: Global-Number of Rubella Incidences by Region (2008)
Figure 7-15: Global-Number of Tuberculosis Incidences by Region ('000), 2008
Figure 8-1: Global-Hepatitis B Surface Antigen Prevalence (%), 2006
Figure 8-2: Global-Hepatitis B Vaccine Market (Billion US$), 2009-2012
Figure 8-3: Global-R&D Investment in AIDS Vaccine Development (Million US$), 2006-2008
Figure 8-4: Global-Sources for Funding in HIV Vaccine R&D (%), 2008
Figure 8-5: Global-Cancer Vaccine Market (Billion US$), 2007, 2008 & 2012
Figure 8-6: Global-Number of Cancer Vaccines in Various Phases of Clinical Developments by Type (Aug 2005)
Figure 8-7: Global-Forecast for Influenza Vaccine Market (Billion US$), 2010-2012
Figure 9-1: Global-Vaccine Market by Region (%), 2008
Figure 9-2: Global-Forecast for Vaccine Market by Region (%), 2012
Figure 9-3: Global-Sales Split of Major Vaccine Players by Region (%), 2004
Figure 9-4: US-Vaccine Market (Billion US$), 2008-2012
Figure 9-5: US-Forecast for Pediatric Vaccine Market (Billion US$), 2010-2012
Figure 9-6: US-Hepatitis Vaccine Market (Billion US$), 2008-2012
Figure 9-7: US-Influenza Vaccine Production by Player (%), 2009
Figure 9-8: US-Influenza Vaccine Production and Consumption (Million Doses), 2004-2005 to 2008-2009
Figure 9-9: US-Influenza Vaccine Sales by Provider (%), 2007-2008
Figure 9-10: US-Influenza Vaccine Market (Million US$), 2009-2012
Figure 9-11: US-Travel Vaccine Market (Million US$), 2008-2012
Figure 9-12: US-Developmental Vaccine Market (Million US$), 2008-2012
Figure 9-13: Europe-Vaccine Market (Billion US$), 2007, 2008 & 2014
Figure 9-14: Europe-Share of Key Players in Vaccine Market (2008)
Figure 9-15: China-Vaccine Market (Billion US$), 2006-2009
Figure 9-16: China-Forecast for Vaccine Market (Million US$), 2010-2012
Figure 9-17: China-Share of Key Players in Vaccine Market (2008)
Figure 9-18: China-Influenza Vaccine Market (Million US$), 2007-2009
Figure 9-19: China-Forecast for Influenza Vaccine Market (Million US$), 2010-2012
Figure 9-20: India-Share of Domestic Consumption and Exports in Vaccine Market (2009)
Figure 9-21: India-Share of Private Sector in Domestic Vaccine Market (2008)
Figure 9-22: India-Vaccine Market (Billion US$), 2008-09 & 2009-10
Figure 9-23: India-Forecast for Vaccine Market (Billion US$), 2010-11 & 2011-12
Figure 9-24: India-Share of Key Players in Vaccine Market (2006-07)
Figure 9-25: Japan-Vaccine Market (Million US$), 2007 & 2008
Figure 9-26: Japan-Influenza Vaccine Production (Million Doses), 2007-08 & 2008-09
Figure 9-27: Japan-Forecast for Vaccine Market (Million US$), 2010-2012
Figure 9-28: Japan-Share of Domestic and Foreign Players in Vaccine Market (2009)
Figure 9-29: Japan-Vaccine Market by Segment (%), 2009
Figure 9-30: Brazil-Vaccine Market (Million BRL), 2007-2009
Figure 9-31: Brazil-Forecast for Vaccine Market (Billion BRL), 2010-2012
Figure 9-32: Brazil-Share of Public and Private Sector in Vaccine Market (2004)
Figure 9-33: Brazil-Share of Key Players in Private Sector Vaccine Market (2008)
Figure 10-1: Global-Dose Consumption and Revenue by Regional Income (%), 2005
Figure 13-1: Global-Vaccine Market by Player (%), 2008

List of Tables:

Table 7-1: Global-Pneumococcal Vaccine Supply
Table 8-1: Global-Number of HIV/AIDS Patients (2008)
Table 8-2: US-Estimated Number of New Cancer Cases and Deaths (2009)
Table 8-3: Global-Five Year Relative Survival Rates by Stage of Cancer Diagnosis (%)
Table 8-4: Global-List of Launched and Under-development Cancer Vaccines by Indication
Table 9-1: China-Number of Reported Cases of Diseases Preventable by Vaccine (2006 & 2007)
Table 9-2: China-Vaccine Classification
Table 9-3: China-Pediatric Vaccine Doses Requirement (Million)
Table 9-4: China-Revenues of Some Vaccine Manufacturing Biological Companies (Million RMB), 2006
Table 9-5: India-Sales of Top Five Vaccine Companies (Million US$), 2008-09
Table 9-6: Japan-Sales of Top Domestic Vaccine Manufacturers (Million Yen)
Table 9-7: Japan-Sales of Top Foreign Vaccine Players (Million Yen)
Table 9-8: Brazil-Public and Private Sector Vaccine Market (Million BRL)
Table 10-1: Health Statistics in Developed and Developing Countries (%)
Table 11-1: Global-Key Mergers & Acquisitions in Vaccine Market (2005 to 2009)
Table 12-1: Global-Top Launched Vaccine Brand Sales (Billion US$), 2009 & 2012
Table 12-2: Global-Forecast for Top Vaccine Brand Sales Under-development (Million US$), 2012
Table 13-1: Global-Vaccine Sales of Top Companies (Million US$), 2008
Table 13-2: Sanofi Aventis-Strengths and Weaknesses
Table 13-3: Novartis-Strengths and Weaknesses
Table 13-4: GSK-Strengths and Weaknesses
Table 13-5: Pfizer-Strengths and Weaknesses
Table 13-6: Global-Major Vaccine Companies (Segmentation by Revenue)